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Despite recent improvements in child survival that have been seen in
most low‐ and middle‐income countries over the past three decades,
child mortality remains unacceptably high and pneumonia remains the
dominant cause of child death outside the neonatal age group. In this
issue of the journal, Graham and colleagues present a rare glimpse into
the management of childhood pneumonia in Africa's most populous
country, Nigeria. The paper describes the management of severe
pneumonia and severe malaria in 12 medium‐sized hospitals, with a
focus on the cases of severe pneumonia and severe malaria by the
World Health Organization (WHO) definition that were given other
diagnoses by the hospital doctors.1 The reader may be advised to begin
by looking through the descriptions of the 12 hospitals in the Web
Appendix, keeping in mind the fact that Nigeria is not a poor country
(Gross National Income per capita $5710 in 2018), yet its under‐five
mortality is close to the worst in the world at 120/105 live births, just
slightly lower than Somalia.2 The hospital review data provide some
clues as to why child survival is so poor in Nigeria. All hospitals had
access to oxygen and antibiotics, but access to oxygen for pediatric
patients was limited.3 In all but one hospital, patients' families were
required to pay for everything. Case fatality rates (CFRs) were mostly
around 4%, which is probably average for West African hospitals. It is
unclear whether these figures reflect children who were withdrawn
from the hospitals because parents were unable to pay the fees. From
the CFR perspective, the worst performing hospital was Hospital no. 3,
which had a CFR of 7.5%. In that hospital, oxygen was available for
$7.50 per day, and an average 3‐day admission for pneumonia cost the
family $60, a lot for the 50% of Nigeria's population who are living in
extreme poverty (<$1.25 per person per day4). Notably, there were no
standard treatment guidelines in use at the hospital.
The authors analyzed data from these 12 hospitals to explore
whether diagnostic issues may have contributed to patient outcomes.
They used clinical data to categorize cases into WHO‐defined severe
pneumonia and WHO‐defined severe malaria. The WHO definition of
severe malaria is a positive laboratory test for malaria in a child with
fever, plus one of severe anemia, reduced conscious state, convul-
sions, or respiratory distress.5 Not surprisingly, most children pre-
senting with these clinical features were recognized by the clinicians
as having malaria. However, with cases classified as WHO‐defined
severe pneumonia, a disturbing proportion of cases (41%) did not
have pneumonia among their admission diagnoses. Adding to the
concern generated by this finding, there was a trend toward higher
mortality in the “missed” cases (12% vs 9%), and those cases were
less likely to receive antibiotics on day 1 (85% vs 96%). So, can we
assume that misdiagnosis by hospital doctors, essentially missing
cases of severe pneumonia, has led to higher mortality?
First, we must consider the specificity of the WHO definition of
severe pneumonia. It was never intended to be used as an epide-
miological tool. Rather, its purpose was to identify children with a
high probability of dying from pneumonia, to refer them for hospital
care, usually involving parenteral antibiotics with or without oxygen.
The WHO definition was established when the Programme for
Control of Acute Respiratory Infections (ARI Programme) was star-
ted in 1987.6 This followed an International Workshop in Australia in
19847 and the publication of the first modeling exercise estimating
the global mortality burden associated with acute respiratory
infections.8 The ARI programme was based on an existing algorithm
that was in place in Papua New Guinea. Primary health care workers
or health workers at first‐level health facilities were trained to
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provide antibiotics for children presenting with cough or difficult
breathing associated with fast breathing (>50 breaths/min). The need
for hospitalization was based on the presence of lower chest wall
indrawing, as described by Shann.9 Since then, three important
changes have taken place.
1. In 1989, the respiratory rate cut‐off point above which children
should be treated was changed from 50 breaths/minute for all
children under 5 years to a stratified level: 0 to 2 months, 60; 2 to
12 months, 50; 12 months to 5 years, 40.
2. Between 1991 and 1995, WHO and UNICEF developed the In-
tegrated Management of Childhood Illness (IMCI) strategy, which
incorporated the ARI Programme algorithm into a broader
strategy including malaria, diarrhea, measles, and malnutrition. A
part of this strategy was the inclusion of nonspecific danger signs
including convulsions, poor conscious state, and inability to feed,
which required a child to be referred for admission for severe
disease not necessarily specified.
3. In 2013, lower chest wall indrawing was dropped as an indication
for admission with severe pneumonia, based mainly on equiva-
lence studies from Pakistan that have been criticized10 for en-
rolling mostly mild cases.
The current WHO definition of severe pneumonia is cough or
difficult breathing with at least one of the IMCI danger signs of con-
vulsions, poor conscious state, or inability to feed. In addition, the
definition includes the difficult to define sign of respiratory distress
and hypoxia measured by pulse oximetry (SpO2 < 90%). None of these
signs are specific for pneumonia, but they are good indicators of
children in need of hospitalization. The inclusion of lower chest wall
indrawing, which is usually a sign of reduced lung compliance, would
increase the specificity of this algorithm for pulmonary disease; how-
ever, the diagnosis could still be bronchiolitis, asthma, or upper air-
ways obstruction. Although the existing approach is appropriate for
identifying those children in need of hospitalization for pneumonia, the
combination of clinical signs used needs to be carefully re‐examined,
particularly in light of a recent large study from Kenya,11 which con-
cluded that 322 of 832 (39%) pneumonia deaths documented in 14
hospitals over 2 years would have been classified by the current WHO
severe pneumonia definition as nonsevere pneumonia, not in need of
hospitalization. It appears that the WHO definition of severe pneu-
monia is not a very convincing gold standard.
So who were the cases of WHO‐defined severe pneumonia who
were missed in the Nigerian study? Diagnoses amongst the “missed”
cases included severe diarrhea, meningitis, and seizures. These could
have been correctly diagnosed and treated for conditions other than
pneumonia, and the inclusion of conditions with higher CFRs (sepsis
and meningitis) would explain the trend toward higher mortality in
the “missed” group. Of greater concern are 349 children in this ca-
tegory who were diagnosed with malaria. With the widespread
availability of rapid diagnostic tests (RDTs), malaria diagnosis is now
available in most health facilities in malaria‐endemic countries.12 A
busy junior doctor facing a waiting room full of patients who sees a
sick young child with a documented fever and a positive RDT may
have a diagnosis before he/she begins to examine the patient. In
endemic countries, a high proportion of healthy young children are
parasitemic, so the presence of parasitemia in a sick child does not
necessarily mean that the child has clinical malaria. In such settings,
when a child presents with fever and convulsions, a positive RDT will
support a diagnosis of cerebral malaria and often no lumbar puncture
(LP) will be performed. There appears to be a decline in the perfor-
mance of LPs, such that many young doctors lack the skills to per-
form the procedure. In some African hospitals, LPs are now rarely
done on young children.13 In most settings, such cases are covered
with antibiotics, as the doctors acknowledge that the child could have
meningitis. Despite this, it is likely that overdiagnosis of malaria leads
to under‐recognition of meningitis and some missed cases leading to
fatal outcomes.
The child presenting with respiratory symptoms and a positive
RDT is a different matter, as the diagnosis of pneumonia in a young
child may be quite difficult and as Graham et al found that the
availability of chest radiography is very limited. Whereas tachypnea
in a child with malaria is an ominous sign,14 the absence of cough is a
useful sign for distinguishing malaria from pneumonia.15 The recent
rapid expansion in the availability of RDTs has probably led to an
under‐diagnosis of pneumonia in favor of malaria. In an African clinic,
the diagnosis of malaria in a young child presenting with fever, a
positive RDT, and tachypnoea is easy, but it will often be wrong. The
danger of any diagnostic test, especially in settings with few such
facilities, is that it will trump any clinical signs and may lead to a more
limited or absent clinical evaluation. In Graham's extraordinary study,
it is likely that some of the additional deaths in the “missed pneu-
monia” group are genuine missed cases of pneumonia, whereas
others are serious conditions that may have been correctly diagnosed
by the attending doctors. However, there may also be other factors
at play here. The nonsignificant increase in deaths in the “missed
pneumonia” group must be viewed against the slightly larger pro-
portion of “detected” severe pneumonia cases who left the hospital
against medical advice, possibly due to the financial cost of the ad-
mission. It is true that this study raises more questions than it an-
swers, but these uncertainties should not detract from this important
study. The reduction in childhood pneumonia mortality should be a
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